Junevity, a biotechnology company on a mission to extend lifespan and healthspan with cell reprogramming, today announced the publication of a peer-reviewed study in Proceedings of the National ...
Hosted on MSN
Algorithm matches drugs to glioblastoma's diverse cell types, offering hope for individualized therapies
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor. This approach enabled them to ...
The Global Cancer Biomarkers Market is projected to grow at a CAGR of 8.6% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market was ...
The future of clinical development hinges on viewing biological systems holistically. By integrating diverse molecular data ...
Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole ...
News-Medical.Net on MSN
Single-cell technique maps pre-malignant gene mutations in solid tissues
A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...
The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.
The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results